Early experimental COVID-19 therapies: associations with length of hospital stay, mortality and related costs | Zendy

Nathalie Vernaz | Zendy; Thomas Agoritsas | Zendy; Alexandra Calmy | Zendy; Angèle GayetAgeron | Zendy; Garry E. Gold | Zendy; Arnaud Perrier | Zendy; Fabienne Picard | Zendy; Virginie Prendki | Zendy; JeanLuc Reny | Zendy; Caroline Samer | Zendy; Jérôme Stirnemann | Zendy; Pauline Vetter | Zendy; Marie-Céline Zanella | Zendy; Dina Zekry | Zendy; Stéphanie Baggio | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Early experimental COVID-19 therapies: associations with length of hospital stay, mortality and related costs

Author(s) -

Nathalie Vernaz,

Thomas Agoritsas,

Alexandra Calmy,

Angèle GayetAgeron,

Garry E. Gold,

Arnaud Perrier,

Fabienne Picard,

Virginie Prendki,

JeanLuc Reny,

Caroline Samer,

Jérôme Stirnemann,

Pauline Vetter,

Marie-Céline Zanella,

Dina Zekry,

Stéphanie Baggio

Publication year - 2020

Publication title -

schweizerische medizinische wochenschrift

Language(s) - English

Resource type - Journals

ISSN - 0036-7672

DOI - 10.4414/smw.2020.20446

Subject(s) - medicine , hydroxychloroquine , lopinavir , ritonavir , lopinavir/ritonavir , confidence interval , propensity score matching , retrospective cohort study , emergency medicine , observational study , pediatrics , covid-19 , disease , human immunodeficiency virus (hiv) , viral load , family medicine , antiretroviral therapy , infectious disease (medical specialty)

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research